Charles River Laboratories International (CRL) Revenue — Quarter Ended Sep 30, 2023
Revenue for the reported quarter declined compared to the immediately preceding quarter. However, revenue was higher than the same quarter one year earlier.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue for the reported quarter declined compared to the immediately preceding quarter. However, revenue was higher than the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1B
Revenue reported for this quarter.
Quarter-over-quarter
-3.1%
Change from the immediately preceding quarter.
Year-over-year
+3.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $1.1B | +21.5% |
| Apr 1, 2023 | $1B | +12.6% |
| Jul 1, 2023 | $1.1B | +8.9% |
| Sep 30, 2023 | $1B | +3.8% |
Revenue performance
The reported quarter's revenue fell sequentially from the prior quarter. On a year-over-year basis, revenue increased relative to the same quarter a year ago.
Quarterly comparison
Revenue in the reported quarter was lower than the preceding quarter's figure. Compared to the same quarter one year earlier, revenue was higher.
What to watch
The sequential decline follows a prior quarter's increase, suggesting potential volatility in the revenue trend.